The reason I brought this up is that both the AstraZeneca and Johnson & Johnson vaccines, as I understand it, are viral vectors. We do have plans and capacity here in Canada to do that, and we now see the Biden administration waiving patents.
I'm going to go back to that question. We're watching the profits of these major pharmaceutical companies tank in the stock market today. I think it's criminal that they profited in the ways they did during this crisis anyways.
Understanding that the patents are being waived, if there's an opportunity for us to take this technology and apply it here locally and domestically in the medium term, could we do that with the existing viral vector technology that we have?